One-year Data: Apremilast Demonstrates Sustained Improvement in Kids With PsO
New one-year data show that apremilast (Otezla, Amgen) results in sustained improvements in disease severity and skin involvement for kids and adolescents with psoriasis. “The main takeaway message is that apremilast is safe and effective in pediatric psoriasis and the only oral agent studied for this indication,” study author Loretta Fiorillo, M.D., FRCPC, clinical professor […]